Azzad Asset Management Inc /Adv Eli Lilly & CO Transaction History

Azzad Asset Management Inc /Adv

  • $891 Billion
  • Q3 2024

A detailed history of Azzad Asset Management Inc /Adv transactions in Eli Lilly & CO stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 1,931 shares of LLY stock, worth $1.44 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,931
Previous 1,735 11.3%
Holding current value
$1.44 Million
Previous $1.57 Billion 8.91%
% of portfolio
0.19%
Previous 0.19%

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
BUY
$772.14 - $960.02 $151,339 - $188,163
196 Added 11.3%
1,931 $1.71 Billion
Q2 2024

Jul 30, 2024
SELL
$724.87 - $909.04 $57,264 - $71,814
-79 Reduced 4.36%
1,735 $1.57 Billion
Q1 2024

Apr 19, 2024
BUY
$592.2 - $792.28 $26,649 - $35,652
45 Added 2.54%
1,814 $1.41 Billion
Q4 2023

Apr 01, 2024
BUY
$525.19 - $619.13 $327,193 - $385,717
623 Added 54.36%
1,769 $1.03 Billion
Q3 2023

Apr 01, 2024
BUY
$434.7 - $599.3 $46,078 - $63,525
106 Added 10.19%
1,146 $616 Million
Q2 2023

Apr 01, 2024
SELL
$350.74 - $468.98 $52,260 - $69,878
-149 Reduced 12.53%
1,040 $488 Million
Q1 2023

Apr 01, 2024
SELL
$310.63 - $364.82 $20,812 - $24,442
-67 Reduced 5.33%
1,189 $408 Million
Q4 2022

Apr 01, 2024
SELL
$321.55 - $374.67 $3.46 Million - $4.03 Million
-10,757 Reduced 89.54%
1,256 $460 Million
Q3 2022

Apr 01, 2024
SELL
$296.48 - $337.87 $994,690 - $1.13 Million
-3,355 Reduced 21.83%
12,013 $2.17 Billion
Q2 2022

Apr 01, 2024
BUY
$278.73 - $327.27 $3.14 Million - $3.69 Million
11,279 Added 275.84%
15,368 $3.26 Billion
Q1 2022

Apr 01, 2024
BUY
$234.69 - $291.66 $150,201 - $186,662
640 Added 18.56%
4,089 $1.17 Billion
Q4 2021

Apr 01, 2024
SELL
$224.85 - $279.04 $30,129 - $37,391
-134 Reduced 3.74%
3,449 $953 Million
Q3 2021

Apr 01, 2024
BUY
$221.6 - $272.71 $35,899 - $44,179
162 Added 4.74%
3,583 $828 Million
Q2 2021

Apr 01, 2024
SELL
$180.55 - $233.54 $4,333 - $5,604
-24 Reduced 0.7%
3,421 $785 Million
Q1 2021

Apr 01, 2024
SELL
$164.32 - $212.72 $1.47 Million - $1.9 Million
-8,954 Reduced 72.22%
3,445 $644 Million
Q4 2020

Apr 01, 2024
BUY
$130.46 - $172.63 $17,351 - $22,959
133 Added 1.08%
12,399 $2.09 Billion
Q3 2020

Apr 01, 2024
BUY
$146.22 - $169.13 $218,452 - $252,680
1,494 Added 13.87%
12,266 $1.82 Billion
Q2 2020

Apr 01, 2024
SELL
$136.42 - $164.18 $175,572 - $211,299
-1,287 Reduced 10.67%
10,772 $1.77 Billion
Q1 2020

Apr 01, 2024
SELL
$119.05 - $147.35 $1.27 Million - $1.58 Million
-10,691 Reduced 46.99%
12,059 $1.67 Billion
Q4 2019

Apr 01, 2024
BUY
$106.92 - $132.43 $10,050 - $12,448
94 Added 0.41%
22,750 $3.34 Billion
Q3 2019

Apr 01, 2024
BUY
$106.79 - $116.16 $930,461 - $1.01 Million
8,713 Added 62.49%
22,656 $3.1 Billion
Q2 2019

Apr 01, 2024
SELL
$110.79 - $129.32 $5,650 - $6,595
-51 Reduced 0.36%
13,943 $1.54 Billion
Q1 2019

Apr 01, 2024
BUY
$111.31 - $131.02 $1,113 - $1,310
10 Added 0.07%
13,994 $1.82 Billion
Q4 2018

Apr 01, 2024
SELL
$105.9 - $118.64 $408,985 - $458,187
-3,862 Reduced 21.64%
13,984 $1.62 Billion
Q3 2018

Apr 01, 2024
SELL
$85.86 - $107.31 $19,232 - $24,037
-224 Reduced 1.24%
17,846 $1.92 Billion
Q2 2018

Apr 01, 2024
BUY
$75.7 - $86.88 $1.37 Million - $1.57 Million
18,070 New
18,070 $1.54 Billion
Q1 2018

Apr 03, 2024
BUY
$74.21 - $87.6 $30,055 - $35,478
405 Added 2.33%
17,766 $1.37 Billion
Q4 2017

Apr 03, 2024
BUY
$81.94 - $87.89 $27,204 - $29,179
332 Added 1.95%
17,361 $1.47 Billion
Q3 2017

Apr 03, 2024
BUY
$77.07 - $85.54 $44,700 - $49,613
580 Added 3.53%
17,029 $1.46 Billion
Q2 2017

Apr 03, 2024
BUY
N/A
2,464 Added 17.62%
16,449 $1.35 Billion
Q1 2017

Apr 03, 2024
BUY
N/A
579 Added 4.32%
13,985 $1.18 Billion
Q4 2016

Apr 03, 2024
SELL
N/A
-1,089 Reduced 7.51%
13,406 $986 Million
Q3 2016

Apr 03, 2024
SELL
N/A
-170 Reduced 1.16%
14,495 $1.16 Billion
Q2 2016

Apr 03, 2024
BUY
N/A
236 Added 1.64%
14,665 $1.15 Billion
Q1 2016

Apr 03, 2024
BUY
N/A
586 Added 4.23%
14,429 $1.04 Billion
Q4 2015

Apr 03, 2024
SELL
N/A
-1,447 Reduced 9.46%
13,843 $1.17 Billion
Q3 2015

Apr 03, 2024
SELL
N/A
-1,016 Reduced 6.23%
15,290 $1.28 Billion
Q2 2015

Apr 03, 2024
SELL
N/A
-2,113 Reduced 11.47%
16,306 $1.36 Billion
Q1 2015

Apr 03, 2024
BUY
N/A
798 Added 4.53%
18,419 $1.34 Billion
Q4 2014

Apr 03, 2024
BUY
N/A
3,502 Added 24.8%
17,621 $1.22 Billion
Q3 2014

Apr 03, 2024
BUY
N/A
8,303 Added 142.76%
14,119 $916 Million
Q2 2014

Apr 03, 2024
SELL
N/A
-19 Reduced 0.33%
5,816 $362 Million
Q1 2014

Apr 03, 2024
BUY
N/A
133 Added 2.33%
5,835 $343 Million
Q4 2013

Apr 03, 2024
BUY
N/A
406 Added 7.67%
5,702 $291 Million
Q2 2013

Apr 03, 2024
BUY
N/A
1,003 Added 23.36%
5,296 $267 Million
Q1 2013

Apr 03, 2024
BUY
N/A
2,524 Added 142.68%
4,293 $244 Million
Q2 2011

Apr 08, 2024
SELL
N/A
-6,539 Closed
0 $0
Q1 2011

Apr 08, 2024
SELL
N/A
-588 Reduced 8.25%
6,539 $230 Million
Q4 2010

Apr 08, 2024
BUY
N/A
5,358
7,127 $250 Million

Others Institutions Holding LLY

# of Institutions
4,003
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email